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Summary
Objective: We have used recombinant osteogenic protein-1 to investigate our hypothesis that proper repair and maintenance of cartilage
requires not only enhanced biosynthesis and replenishment of the extracellular matrix but also the enhancement of components necessary
for matrix retention.
Design: The effects of osteogenic protein-1 were examined on bovine articular cartilage slices as well as isolated chondrocytes grown in
alginate beads. Cartilage slices were examined for accumulation of proteoglycan by incorporation of 35S-sulfate and staining using Safranin
O or, a biotinylated probe specific for hyaluronan. Bovine chondrocytes were characterized by use of a particle exclusion assay, in-situ
hybridization, quantitative-competitive RT-PCR and a hyaluronan-binding assay.
Results: Osteogenic protein-1 treatment substantially enhanced the accumulation of hyaluronan and proteoglycan within cartilage tissue
slices. As with the tissue, osteogenic protein-1 enhanced the size of cell-associated matrices assembled and retained by chondrocytes in
vitro. This enhanced matrix assembly was paralleled by an increased expression of mRNA for aggrecan, hyaluronan synthase-2 and CD44.
Of the two hyaluronan synthase genes expressed by chondrocytes, only hyaluronan synthase-2 was upregulated by osteogenic protein-1.
Coupled with the increase in the CD44 mRNA was an increase in functional hyaluronan binding activity present at the chondrocyte cell
surface.
Conclusions: These results demonstrate that osteogenic protein-1 stimulates not only the synthesis of the major cartilage extracellular matrix
component aggrecan, but also two associated molecules necessary for the retention of aggrecan, namely hyaluronan and CD44. © 2000
OsteoArthritis Research Society International
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Articular cartilage is a highly specialized tissue composed
of a small number of cells, the chondrocytes, embedded in
an extensive extracellular matrix. Assembly and turnover of
cartilage extracellular matrix must be carefully controlled
and coordinated to insure the unique integrity of this tissue.
Cartilage extracellular matrix is composed principally of
collagen type II and the aggregating proteoglycan (PG),
aggrecan. Aggrecan monomers, often more than 50, are
bound to single filaments of hyaluronan (HA) to form PG
aggregates.1 In addition, HA also facilitates the anchorage
of HA-PG aggregates to the surface of the chondro-
cytes within cartilage, the chondrocytes. We have demon-
strated that aggregates are tethered to the chondrocyte cell127surface via interactions with CD44, the principal HA
receptor.2,3 Thus these components, namely CD44, HA
and aggrecan, comprise three important elements for
pericellular matrix assembly and maintenance of matrix
homeostasis around the cells.
The etiology of osteoarthritis is multifactorial. Among the
many alterations in the structure of cartilage that character-
ize osteoarthritis, the most remarkable and consistent is a
loss of PGs.4 However, since the retention of aggrecan
within the cartilage matrix is dependent on the presence
of optimal concentrations of HA as well as associated
functional HA receptors such as CD44, the relationship
between these three components in osteoarthritis needs to
be established. Depletion of HA has been observed in early
stages of experimental osteoarthritis in dogs.5 Reduced
joint loading due to splint immobilization in dogs also
resulted in a significant decrease of HA in articular carti-
lage.6 In the anterior cruciate ligament transection dog
model of osteoarthritis it is still uncertain whether
decreased synthesis or increased degradation lead to the
reduction of HA. However, in the unloaded canine cartilage
model, decreased HA synthesis appears to be responsible
for the loss of matrix.7,8 On the other hand, a previous
study from our laboratory demonstrated that inhibition of
CD44 expression, via antisense oligonucleotides, induced
nearly total loss of the PG-rich matrix from bovine articular
128 Y. Nishida et al.: OP-1 promotes matrix synthesis and retentioncartilage.9 Taken together, these studies indicate that HA
and CD44 play pivotal roles to retain and maintain the
extracellular matrix.
Osteogenic protein-1 (OP-1), also known as bone
morphogenetic protein-7 (BMP-7), is a member of the
transforming growth factor- superfamily, the members of
which have many regulatory functions in mammalian
embryonic development.10 Bone morphogenic proteins
were originally characterized by the capability of inducing
de-novo bone formation when injected subcutaneously in
rats,11 and have been shown to play an important role in
cartilage differentiation12–15 and the regulation of skeletal
formation.16,17
Recent studies have shown that recombinant OP-1
stimulates type II collagen and PG synthesis in bovine and
human articular chondrocytes without inducing chondro-
cyte hypertrophy.18,19 However, there have been no
studies examining the more physiological effects of OP-1
on articular chondrocytes, such as on pericellular matrix
retention. In the present study, we demonstrate that treat-
ment of bovine articular chondrocytes with OP-1 stimulates
hyaluronan synthase-2 (HAS-2) and CD44 mRNA expres-
sion as well as aggrecan, resulting in an increase in the
diameter of functional pericellular matrix. Fluorescein-HA
binding studies indicate that the increase in CD44 mRNA is
correlated with an increase in functional HA receptors
present at the chondrocyte cell surface. Furthermore, OP-1
promotes PG and HA retention in cartilage explant cultures.
Thus, OP-1 stimulates not only the synthesis of type II
collagen and PG but also HA and CD44, which play a
pivotal role to maintain the pericellular matrix, resulting in
an increase of pericellular matrix formation.Materials and methods
CELL CULTURE
Metacarpophalangeal joints from 18-month-old steers
were obtained from a local slaughterhouse. Full-thickness
slices of articular cartilage were dissected under aseptic
conditions and subjected to sequential pronase and colla-
genase digestion to liberate chondrocytes from tissues.20
Isolated chondrocytes were cultured in DMEM/Ham’s F-12
+5% fetal bovine serum (FBS) in alginate beads with daily
medium changes.20 After 5 days in culture, the chondro-
cytes were treated with 100 ng/ml of recombinant human
OP-1 (Creative Biomolecules, Hopkinton, MA) in the pres-
ence of 5% FBS for periods of up to 2 weeks. This
concentration of OP-1 was chosen as early preliminary
evidence demonstrated a dose dependent increase in PG
biosynthesis reaching a plateau at OP-1 concentrations
≥100 ng/ml (data not shown).TISSUE CULTURE
Full-thickness slices (∼1×10×10 mm) of bovine articular
cartilage from the metacarpophalangeal joints were cul-
tured directly in 1.0 ml of medium containing 10% FBS.
Following 2 days of culture for recovery, the tissue slices
were treated with or without 100 ng/ml of OP-1 in the
presence of 10% FBS. Following 7 and 14 days of incu-
bation the slices were removed and embedded in Histo
PrepY (Fisher) freezing medium. Cryostat sections
(8.0 m) were prepared and stained with safranin O/fast
21 22green or for HA.STAINING FOR HYALURONAN
Cryostat sections of cartilage slices mounted onto glass
slides were fixed with 2% paraformaldehyde buffered with
PBS at room temperature for 2 h. Tissue sections were
pre-treated with 2 units/ml of chondroitinase ABC (at
pH 8.0) for 2 h at 37°C for unmasking, treated with 0.3%
H2O2 in 30% methanol for 30 min at room temperature to
block the internal peroxidase activity, and then incubated
with 1% bovine serum albumin (BSA) in PBS for 1 h at
room temperature. Sections were then incubated with
2.0 g/ml of a biotinylated HA binding protein (HABP) probe
(Seikagaku USA, Ijamsville, MD) for 2 h at room tempera-
ture followed by a streptavidin-peroxidase reagent
(Vectastain kit) and diaminobenzidine-containing substrate
solution (Sigma FastY DAB). As a control, tissue
sections were pre-treated with 5 units/ml Streptomyces
hyaluronidase for 1 h at 60°C.RADIOINCORPORATION STUDIES
After 5 days of treatment with or without 100 ng/ml of
OP-1, cartilage explants were radiolabeled with 35S-sulfate
(20 Ci/ml) for 4 h followed by incubation in complete
medium minus 35S-sulfate for 24 h to remove all unincor-
porated label. The tissues were then embedded in Histo
PrepY freezing medium, 8 m cryostat sections were
prepared, dehydrated through a graded series of alcohols
containing 300 mM ammonium acetate, dipped in NTB2
emulsion (Kodak), exposed for 4 days at 4°C, and
developed in D-19 developer (Kodak). Sections were
photographed under bright-field microscopy.PARTICLE EXCLUSION ASSAY
Cell-associated pericellular matrices were visualized
using a particle exclusion assay.2 Following treatment of
alginate bead cultures with or without 100 ng/ml of OP-1,
the alginate was depolymerized in 55 mM sodium citrate
releasing the chondrocytes into a single cell suspension.
The cells were ‘splatted’ onto 6-well flat-bottom plates by
centrifugation at 500 g for 15 min.23 The medium was
removed and replaced with a 0.75-ml suspension of
formalin-fixed erythrocytes (108 cells per ml) in PBS con-
taining 0.1% BSA. The particles were allowed to settle for
15 min and the cells photographed using a Zeiss inverted
phase-contrast microscope with Varel optics.BINDING OF FLUORESCEIN-HYALURONAN TO CHONDROCYTES
After 5 days of recovery in alginate beads, and following
5 days of treatment with or without 100 ng/ml of OP-1,
chondrocytes were analyzed for the functional binding of
fluorescein-conjugated HA (fl-HA).24 The chondrocytes
were released from alginate and incubated with testicular
hyaluronidase (30 units/ml) for 60 min at 37°C in media
containing 10% FBS to free the cells of their HA-rich
pericellular matrix. The cells were then incubated in sus-
pension cultures in medium containing 100 g/ml of fl-HA,
in the continued presence or absence of OP-1 for 24 h.
Fl-HA was prepared as described previously from our
laboratory.24 The chondrocytes were collected by tritura-
tion, washed twice with PBS to remove unbound fl-HA, and
pelleted by centrifugation. Following cell counting, triplicate
aliquots were transferred to a fluorescence ELISA plate.
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using a Bio-Tek FL500 fluorescence plate reader.RNA ISOLATION
Total RNA was isolated from chondrocytes that had been
cultured in alginate treated with or without OP-1. Chondro-
cytes were first released from alginate by treatment with
55 mM sodium citrate, followed by a 10-min digestion with
0.25% trypsin/EDTA. The cells were then washed once
with PBS and total RNA was extracted using Trizol (Life
Technologies, Grand Island, NY) following the manufac-
turer’s instructions. Total RNA was also isolated directly
from cartilage slices with or without OP-1 treatment. Carti-
lage slices were transferred into liquid nitrogen, ground into
a powder, and subjected to Trizol extraction. RNA was
dissolved in diethyl pyrocarbonate-treated H2O, and the
concentration of the RNA samples was measured by its
absorbance at 260 nm.QUANTITATIVE COMPETITIVE POLYMERASE CHAIN REACTION,
USING REVERSE TRANSCRIPTASE (RT-PCR)
Total RNA was subjected to reverse transcription and
quantitative competitive PCR. Briefly, 0.25 g of total RNA
was converted to cDNA using Molony murine leukemia
virus reverse transcriptase in the presence of 0.15 M
HAS-2, HAS-3, CD44 or aggrecan-specific downstream
primers (HAS-2: 5′-CTC GGA AGT AGG ACT TGC TCC
AAC GG-3′, HAS-3: 5′-CAG AAG GCT GGA CAT ATA GAG
GAG GG-3′, CD44: 5′-AAC CGC GAG AAT CAA AGC CAA
GGC C-3′, and aggrecan: 5′-CTC CAC TGC CTG TGA
AGT CAC CAC-3′). DNA fragments that share the same
primer template sequence with the target cDNA but, con-
tain a completely different, smaller or larger intervening
sequence, were prepared and used as DNA internal stan-
dards (i.e., mimics,22,24). Aliquots of sample cDNA mixed
together with serial dilutions of DNA mimics were
co-amplified as templates in the presence of downstream
primers and 0.15 M upstream primers for HAS-2, HAS-3,
CD44 or aggrecan (HAS-2: 5′-ACA CAG CCT TCA GAG
CAC TGG GAC-3′, HAS-3: 5′-AGA GAC CCC CAC TAA
GTA CCT CCG-3′, CD44: 5′-GAT CCA CCC CAA TTC CAT
CTG TGC-3′, aggrecan: 5′-GCA CCA TGC CTT CTG CTT
CCG AG-3′), in a PCR mixture consisting of 2 mM magne-
sium chloride, 200 M of each deoxyribonucleotide, and
2.5 units of AmpliTaq DNA polymerase. The DNA was
denatured by heating at 95°C for 2 min, followed by 1 min
cycles at 95°C (23 cycles for HAS-2, 28 cycles for HAS-3,
20 cycles for aggrecan, 22 cycles for CD44), with annealing
at 60°C (64°C for HAS-3), and extension at 72°C for 1 min
(Perkin Elmer thermocycler). This reaction was followed by
a final elongation step that lasted 5 min at 72°C. The
amplified products were analyzed by electrophoresis on
1.5% agarose gels followed by staining with SYBR green I
(Molecular Probes). The stained products were scanned
and quantified using a fluoroimaging system and Image-
QuaNT software (FluorImager 860; Molecular Dynamics).
To determine that all samples contained equivalent
amounts of RNA (or to normalize results due to small
differences), in a separate set of reactions, total RNA from
samples were co-amplified in the presence of serial dilu-
tions of an RNA internal standard (mimic) prepared for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
The GAPDH RNA mimic shares the same primer templatesequence but contains a smaller intervening sequence.
Samples containing 0.25 g of sample total RNA were
co-reverse transcribed with two-fold serial dilutions of
GAPDH RNA mimic in the presence of 0.15 M GAPDH-
specific downstream primer (5′-TTA CTC CTT GGA GGC
CAT GTG GGC C-3′). The sample and mimic cDNA
products were then co-amplified in the presence of the
GAPDH-specific downstream primer together with 0.15 M
upstream primer (5′-ACT GCC ACC CAG AAG ACT GTG
GAT GG-3′) using PCR conditions as described for HAS-2
amplification.IN-SITU HYBRIDIZATION
Digoxigenin-labeled antisense oligonucleotide probes for
HAS-2, CD44 and aggrecan were prepared by 3′ end-
labeling as per manufacturer’s protocol (Boehringer
Mannheim). Articular chondrocytes in alginate beads cul-
tured with or without 100 ng/ml of OP-1 for 7 days were
released and plated into 96-well plates. The chondrocytes
were cultured an additional 12 h in monolayer in the pres-
ence or absence of OP-1. Chondrocytes were fixed in 4%
paraformaldehyde, 5% acetic acid and 0.9% NaCl. After
standard pretreatments and digestion with proteinase K
(20 mg/ml in 50 mM Tris HCl, pH 8, 5 mM EDTA at 37°C for
10 min), the digoxigenin-labeled oligonucleotides probes
were added to the hybridization buffer containing 60%
deionized formamide, 300 mM EDTA, 25 mM NaH2PO4(pH 7.4), 5% dextran sulfate, and 250 ng/l sheared
salmon sperm DNA. In control experiments, digoxigenin-
labeled sense oligonucleotides or unlabeled antisense
probes were used. Hybridization was performed for 16 h at
27°C followed by 3 post-hybridization washes in 60%
formamide, 300 mM NaCl, and 30 mM sodium citrate. After
blocking, the cells were incubated with anti-digoxigenin
alkaline phosphatase-conjugated antibodies for 3 h at room
temperature, and visualized with 5-bromo-4-chloro-3-
indolylphosphate, and nitroblue tetrazolium chloride.ResultsEFFECT OF OP-1 ON PROTEOGLYCAN AND HYALURONAN
DEPOSITION IN BOVINE ARTICULAR CARTILAGE SLICES
Slices of bovine metacarpophalangeal cartilage are rela-
tively stable in explant culture for 1–2 weeks. In fact, in the
presence of 5% FBS, there was little detectable difference
between control untreated and OP-1 treated cartilage
tissue slices as viewed by safranin-O staining. However,
under serum-free conditions for 7 days, a loss of the
stainable PG was detected in the tissue (Fig. 1A). In the
presence of 100 ng/ml OP-1, safranin-O positive staining
PG was maintained within the tissue cultured in serum-free
conditions (Fig. 1B), even after two weeks in culture. Lower
power views (insets to Fig. 1A and B) illustrate that the
increase in Safranin O staining was detected throughout
the various layers of the cartilage tissue. To determine
whether the OP-1 induced maintenance of PG was due to
increased retention or increased biosynthesis, the tissues
were first analyzed for HA using a biotinylated HABP probe
for staining. As shown in Fig. 1C, control untreated carti-
lage slices were clearly positive for HA with definitive
staining throughout the extracellular matrix. Deeper layers
of the cartilage displayed prominent staining of HA in close
proximity to the chondrocytes (i.e., within the pericellular
130 Y. Nishida et al.: OP-1 promotes matrix synthesis and retentionFig. 1. Safranin-O staining and hyaluronan deposition in cultured tissue slices. Bovine articular cartilage slices were cultured without or with
100 ng/ml of OP-1 for 7 days in the absence of FBS, cryostat sectioned, and the sections stained with safranin-O/fast green. Panels A and
B depict sections derived from cartilage slices cultured without or with OP-1 treatment, respectively. Insets to panels A and B depict lower
power magnifications. To detect HA, the cryostat sections were fixed in 2% paraformaldehyde and stained using a biotinylated HABP
followed by streptavidin peroxidase. Panels C and D depict the sections derived from cartilage without or with OP-1 treatment, respectively.
Insets to panels C and D depict HABP staining from another representative experiment. As a negative control, sections were pre-treated with
Streptomyces hyaluronidase. The hyaluronidase treated sections were nearly transparent and completely unstained (data not shown).
Sections shown are representative pairs of three independent experiments. Magnification bars in all panels represent 100 m.Fig. 2. Proteoglycan synthesis in cultured tissue slices. Bovine articular cartilage slices cultured with or without 100 ng/ml of OP-1 in the
presence of FBS for 5 days were radiolabeled with 35S-sulfate for 4 h followed by 24 h of incubation in unlabeled medium. After the chase
incubation the tissues were sectioned, exposed and developed for autoradiography. Panel A is the control tissue and panel B represents the
paired OP-1 treated tissue photographed using bright-field microscopy. The sections are representative of paired tissues from two
independent experiments.and territorial matrix). However, in the presence of OP-1,
the staining for HA was substantially increased (Fig. 1D)
more prominent both within the matrix and surrounding the
cells. HABP staining of another pair of tissues from another
experiment (of three experiments) display similar results
(Fig. 1C and D, insets).
In order to investigate the effect of OP-1 on PG synthesis
in these explant tissue slices, incorporation of radiolabeledprecursor (35S-sulfate) was visualized by autoradiography.
As shown in Fig. 2, although control untreated cartilage
tissues maintain a capacity for PG biosynthesis (panel A),
one-week treatment with OP-1 resulted in a significant
increase in 35S-sulfate incorporation (panel B). Developed
grains are seen not only adjacent to the chondrocytes but
appear to be diffusing out into the surrounding matrix. Thus
OP-1 treatment of intact tissue slices appears to have the
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accumulation of HA.Fig. 3. The effect of OP-1 on the cell-associated matrix of bovine articular chondrocytes. Bovine articular chondrocytes were cultured in
alginate beads in the presence or absence of 5% FBS, with or without OP-1 for 7 days, released from alginate and transferred into 6-well
culture plates. Fixed erythrocytes were applied to the plated chondrocytes to visualize the cell-associated matrix. Panels A and B depict
control, untreated chondrocytes cultured in the presence of 5% FBS; panel C control chondrocytes in the absence of serum. Chondrocytes
were also cultured with OP-1 in the presence (panels D and E) or absence (panel F) of 5% FBS. Cells in each panel are representative
results of one of three independent experiments. Panels A and D depict lower power magnification views of cells shown in panels B and E,
respectively and illustrate the uniformity of the coat size for each condition. Magnification of panels A, B and C is equivalent to that indicated
by the bars in D, E and F, respectively.EFFECT OF OP-1 ON MATRIX ASSEMBLY BY BOVINE ARTICULAR
CHONDROCYTES IN CULTURE
Bovine articular chondrocytes were cultured in alginate
beads with or without 100 ng/ml of OP-1 for 7 days. This
three-dimension culturing system maintains the chondro-
cyte phenotype and provides a permissive environment for
optimal cell recovery following the somewhat harsh
pronase/collagenase treatment used to isolate the cells
from the tissue.20,24 Nonetheless, in the presence of
calcium chelators the alginate gel depolymerizes and the
chondrocytes can be collected as single cells. In this
manner, following centrifugation of the single-cell suspen-
sion to attach the chondrocytes to a culture plastic sub-
stratum, the retained cell-associated matrix can be
visualized using a particle exclusion assay. As shown in
Fig. 3, panels A and B, control chondrocytes grown for
5 days in the presence of FBS all exhibited a prominent
cell-associated matrix, that excluded particles to a distanceof approximately one-half cell diameter. Of eighteen control
cells (in the presence of serum) analyzed by morphometric
analysis, 83.3% of the cells exhibited matrices with a width
of approximately one-half cell diameter, 16.7% exhibited
larger matrices approaching one cell diameter. Under
serum-free conditions for 7 days, the control chondrocytes
still exhibit a particle excluding matrix (Fig. 3, panel C) but
one that is not as extensive as chondrocytes grown in the
presence of serum. However, 7 days of treatment of OP-1
resulted in a substantial enhancement in the diameter of
the cell-associated matrix both in the presence (Fig. 3D and
E) or absence (Fig. 1F) of serum. Under these conditions,
particles were excluded to a distance equivalent to an
entire cell-diameter and represent some of the largest
‘coats’ viewed surrounding eukaryotic cells.25 Of fourteen
OP-1 treated chondrocytes (in the presence of serum)
analyzed by morphometric analysis, 35.7% exhibited
matrices smaller than one cell-diameter while 64.3% of the
cells exhibited large matrices equivalent in width to one-cell
diameter or larger. Although not shown, the increase in
cell-associated matrix size due to OP-1, was time depen-
dent showing visible differences as compared to control
132 Y. Nishida et al.: OP-1 promotes matrix synthesis and retentioncultures between 1 and 7 days with a maximal at 7 days as
shown in Fig. 3.EFFECT OF OP-1 ON CHONDROCYTE GENE EXPRESSION OF
AGGRECAN, HA SYNTHASE AND CD44
We have shown previously that the assembly of
chondrocyte cell-associated matrices, such as those
shown in Fig. 3, depend on the presence three components
namely, aggrecan, HA and CD44.22,3,26 To investigate the
effects of OP-1 on the expression of these molecules, the
mRNA levels of aggrecan, hyaluronan synthase-2 (HAS-2),
hyaluronan synthase-3 (HAS-3) and CD44 were deter-
mined by quantitative competitive RT-PCR analysis. Fig. 4,
panels A–D, shows the results of a representative competi-
tive RT-PCR analysis carried out on samples of 7 day OP-1
treated chondrocytes (lanes 1–4) and untreated control
chondrocytes (lanes 5–8). Isolated RNA from these
samples was reverse transcribed and amplified using
primers specific for HAS-2, HAS-3, aggrecan and CD44
(panels A–D respectively) as well as GAPDH. Total RNA
isolated from treated and untreated cultures was co-
amplified with serial dilutions of the internal standard DNA
(mimic). Using the internal standard mimics to quantify
RT-PCR products and GAPDH to normalize the data, the
ratios of copy numbers of mRNA expression derived from
OP-1 treated cultures versus control cultures were deter-
mined and plotted as shown in Fig. 4, panel E. The data
shown are the average ratio determined from three inde-
pendent experiments. As can be seen in panel E, OP-1
treatment resulted in a three-fold increase in HAS-2 mRNA,
a two-fold increase in CD44 mRNA and 4.2-fold increase in
aggrecan message. Interestingly, in contrast with the
increased expression of HAS-2 mRNA by OP-1, HAS-3
gene expression was not affected by OP-1 treatment.
To investigate the effect of OP-1 on HAS mRNA expres-
sion in the articular cartilage slices, total RNA was isolated
directly from cartilage slices that were incubated with or
without OP-1 for 3 days, and subjected to competitive
quantitative RT-PCR using methods similar to those
detailed in Fig. 4. The quantified data are expressed as
mRNA copy numbers normalized by GAPDH (Table I). As
can be seen, HAS-2 mRNA expressed in control cultures
was approximately 20-fold higher than that of HAS-3 and
moreover, 80-fold higher in OP-1 treated cultures. Whereas
the HAS-2 mRNA expression was stimulated approxi-
mately 3.5-fold by OP-1, HAS-3 expression, as in the
chondrocyte cultures, was not affected by OP-1. These
data suggest that the increased accumulation of HA
observed in Fig. 1D was due, in part, to an increase in HA
synthesis, with HAS-2 representing the predominant
synthase used by articular cartilage chondrocytes.Fig. 4. The effect of OP-1 on HAS-2, HAS-3, CD44 and aggrecan
mRNA expression by bovine articular chondrocytes cultured in
alginate. Aliquots of total RNA derived from bovine articular
chondrocytes cultures treated with or without 100 ng/ml of OP-1 for
7 days, were reverse transcribed and PCR amplified. The products
were separated on 1.5% agarose gel and visualized by SYBR
green I staining. Lanes 1–4, respectively, represent RNA from
OP-1 treated cultures co-amplified with 30, 10, 3.33 and 1.11
attomoles of HAS-2 DNA mimic (panel A), with 0.3, 0.15, 0.075 and
0.0375 attomoles of HAS-3 DNA mimic (panel B), with 1.6, 0.8, 0.4
and 0.2 femtomoles of aggrecan DNA mimic (panel C), and with
0.4, 0.2, 0.1 and 0.05 attomoles CD44 DNA mimic (panel D).
Lanes 5–8 represent RNA from control cultures co-amplified with
an identical dilution of each mimic. Lanes denoted ‘Sd’ represent
X174/Hae III DNA marker bands. HAS-2 target, 498 bp; mimic,
370 bp. HAS-3 target, 331 bp; mimic, 421 bp. Aggrecan target,
753 bp; mimic, 512 bp. CD44 target, 602 bp; mimic, 379 bp. After
normalization with competitive RT-PCR using GAPDH RNA mimic,
the ratio of mRNA copy numbers, of cultures derived from
OP-1 treated and control cultures were plotted for each molecule
(panel E).IN-SITU HYBRIDIZATION OF CHONDROCYTES RELEASED FROM
ALGINATE
In-situ hybridization was used to detect and visualize
changes in aggrecan, HAS-2 and CD44 mRNA expression
within the chondrocytes treated with or without OP-1.
Digoxigenin-labeled antisense oligonucleotide probes used
and the dark blue diaminobenzidine reaction product indi-
cates hybridization. As shown in Fig. 5, bovine articular
chondrocytes treated with OP-1 revealed a significant
increase in HAS-2 (panel B), CD44 (panel D) and aggrecan
(panel F) mRNA expression, as compared to controluntreated cultures (panels A, C and E, respectively). Insets
in the lower right hand corner of each panel depict lower
power magnification views of the same cultures and illus-
trate the uniformity of the staining for each condition.
Digoxigenin-labeled sense oligonucleotides were used as
a negative control and resulted in no positive staining
(Fig. 5B, upper right inset). Although these in-situ hybrid-
ization results do not allow for accurate quantification of
mRNA expression they are consistent with the competitive
RT-PCR studies described above and, further, represent
the expression of non-amplified mRNA.
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CHONDROCYTES
Increased capacity for matrix retention, such as
observed in Figs 1B, 4C and D, may represent not only an
increase in the synthesis of matrix components but also an
increase in matrix anchoring proteins. To investigate the
effect of OP-1 on functional cell surface-associated HA
binding activity, OP-1 treated and untreated bovine articular
chondrocytes were tested for ligand binding capacity using
fluorescein-conjugated HA (fl-HA) at saturating concen-
trations. As shown in Fig. 6, following treatment with OP-1,
the amount of fl-HA bound at the cell surface was approxi-
mately 1.5-fold higher than that of control cultures. These
results indicate that part of the OP-1 induced increase in
the size of the cell-associated matrix assembly may be due
to an increase in functional HA-binding activity correlated
with the increased CD44 expression at the chondrocyte cell
surface. However, given that these results reflect the over-
all binding capacity of the entire chondrocyte monolayer,
it is, as yet, not known whether the increased binding
capacity is uniform or due to a subpopulation of cells.Table I
Effect of OP-1 on HAS-2 and HAS-3 mRNA expression in bovine
cartilage tissues mean (s.e.m.)
Control OP-1
HAS-2 123 (11) 413 (43)
HAS-3 5.3 (1.4) 5.1 (1.2)
Bovine articular cartilage slices were cultured with or without
treatment of OP-1 for 72 h in the presence of 10% FBS. Total RNA
was isolated directly from the cartilage slices, and subjected
to competitive quantitative RT-PCR. Copy numbers of target
mRNA were calculated by the amount of mimic, which was initially
added to the PCR reaction. The copy numbers of GAPDH mRNA
expressed in each tissue normalized these copy numbers.
Data represent the mean±standard deviation (copy numbers/104
copy numbers of GAPDH) from three independent cultures.
Note: bovine articular chondrocytes express approximately 2×108
copies of GAPDH per g RNA.Fig. 5. Expression of HAS-2, CD44 and aggrecan mRNA in bovine
articular chondrocytes. Bovine articular chondrocytes cultured in
alginate with or without 100 ng/ml of OP-1 for 3 days were
released from the beads and plated onto the 96-well plate over-
night with or without OP-1, and subjected to in situ hybridization.
The chondrocytes were hybridized with digoxigenin-labeled anti-
sense oligonucleotide probes; HAS-2: panels A and B; CD44:
panels C and D; aggrecan: panels E and F. Cells in panels A, C
and E depict control, untreated chondrocytes; in panels B, D and F,
chondrocytes treated with OP-1. Magnification bar in panel E is
equivalent for all panels. As a negative control, digoxigenin-labeled
sense oligonucleotide probe was used (panel B, upper inset).
Insets in the lower right hand corner of each panel depict lower
power magnification views of the same cultures and illustrate the
uniformity of the staining for each condition.Discussion
Osteoarthritis is a degenerative disease of articular
cartilage resulting from inherent changes in the metabolism
of chondrocytes.4 One important pathogenic feature of this
arthropathy is the loss of matrix macromolecules from the
cartilage, especially the PG aggrecan. In some experimen-
tal systems such as the joint immobilization model, loss of
PG is accompanied by a depletion of HA within the extra-
cellular matrix.6 Thus, loss of PG may be due to increased
PG degradation via elevated matrix metalloproteinase
activity,27 inhibition of PG biosynthesis,24,28 and/or an
inhibition of PG retention due to deficits in HA. In order to
replenish the extracellular matrix lost due to osteoarthritic-
like changes, it will likely be necessary to increase not only
the biosynthesis of matrix macromolecules such as PG, but
also, the molecules necessary for retention of the PG within
the cartilage. It has been shown previously that the mor-
phogenic protein OP-1 stimulates the biosynthesis of
aggrecan as well as type II collagen.18,19 In this study, we
demonstrate that in addition to increased aggrecan bio-
synthesis, OP-1 also upregulates the expression of HA
and, the principal chondrocyte HA receptor, CD44. The
stimulation of these three components was observed as asignificant upregulation of aggrecan, HAS-2 and CD44
mRNA as well as the accumulation of extracellular matrix
products and functional activity.
Although increased PG accumulation can clearly be
observed within the OP-1 treated cartilage slices, it is more
difficult to determine the mechanism(s) responsible for
these changes. Although PG as well as HA biosynthesis is
upregulated, does OP-1 treatment also affect an increased
capacity for PG retention? To address this question we
tested the effects of OP-1 on isolated bovine articular
chondocytes grown in alginate bead cultures. Suspension
in alginate beads allows experimentation on isolated
chondrocytes yet maintains their phenotype even over long
culture periods.20 This avoids questions that could be
raised over the effects of OP-1 added to chondrocytes in
monolayer culture, where part of the response may be from
that of fibroblastic cells (i.e., ‘de-differentiated chondro-
cytes’). It is important to note that the expression of
134 Y. Nishida et al.: OP-1 promotes matrix synthesis and retentionFig. 6. Binding of fluorescein-conjugated HA to bovine articular
chondrocyte. Following 5 days of culture in alginate beads, bovine
articular chondrocytes were cultured in the absence or presence of
100 ng/ml OP-1 for 5 days. During the last 24 h of incubation,
100 g/ml fl-HA was added to each of the cultures. The cultures
were processed and fluorescence detected with a plate reader.
Data represent the mean±standard deviation of triplicate determi-
nations. Differences in binding capacity were statistically significant
with a P value=0.031.aggrecan mRNA, which is often used as a phenotypic
marker of the chondrocyte phenotype, remains stable in
alginate bead cultures of chondrocytes even after 6 weeks
of culture with or without OP-1 treatment (data not shown).
Using this system, the current study demonstrates that
OP-1 treatment of chondrocytes results in an increase in
CD44 mRNA expression and also, an increased functional
capacity of the chondrocytes to bind HA to their cell surface
(Fig. 6). This increased capacity, coupled with increased
biosynthesis of aggrecan and HA, resulted in a near
doubling of the diameter of the cell-associated matrix
(Fig. 3). Thus an increased capacity for retention of PG
is likely part of the mechanism of OP-1 induced PG
accumulation.
We have shown in previous studies that these
cell-associated matrices, that can exclude a boundary of
particles (such as is shown in Fig. 3), consist primarily of
aggrecan bound on a scaffold of HA filaments, with the HA
in turn tethered to the plasma membrane of chondrocytes
via its interaction with CD44 receptors.25 Blocking CD44 –
HA interactions results in the displacement of chondrocyte
cell-associated matrices. Furthermore, the continued
presence of blocked CD44 inhibits the re-assembly of an
endogenous cell-associated matrix.25 If the matrix is
removed enzymatically such as by treatment with Strepto-
myces hyaluronidase, the addition of purified exogenous
HA and PG can substitute for endogenous macromolecules
and, via their interaction with CD44, re-assemble a cell-associated matrix in as little as 2 h.2,3,26 In these exper-
iments the exogenous PG is always added in excess.
Although the exogenous matrices are slightly larger than
those that assemble using endogenous, newly synthesized
HA and PG, they are far smaller than the matrices of OP-1
treated chondrocytes observed in the current studies
(Fig. 3C and D). These findings again suggest that
increases in PG and HA alone are insufficient to generate
large cell-associated matrices; increases in CD44 and
overall HA binding capacity are also likely required.
The results of this study also suggest that bovine HAS-2
is the primary enzyme responsible for the synthesis of HA
in bovine articular chondrocytes/cartilage. Increases in HA
due to OP-1 treatment were reflected solely by increases in
HAS-2 mRNA expression. The expression level of bovine
HAS-3 mRNA was significantly lower than that of HAS-2
and showed no change following treatment of chondro-
cytes or cartilage slices with OP-1. This suggests that the
HAS-2 gene is responsible for the increased HA deposition
by chondrocytes stimulated with OP-1. Actually, there are
three related mammalian HAS genes that have been
recently cloned by several groups.29 Each of the HAS
genes is localized on separate chromosomes.30 Recently,
separate functions for each of these HAS genes have been
determined.31 Each enzyme synthesizes HA but at different
rates and terminating with polymer chains of differing size.
However, only the expression of HAS-2 and HAS-3 mRNA
was found in bovine articular chondrocytes. No expression
of HAS-1 mRNA could be detected by RT-PCR even with
high amplification cycle number (data not shown). We
recently observed similar results for human articular
chondrocytes, i.e., only HAS-2 and HAS-3 mRNA were
detectable by RT-PCR, whereas HAS-1 mRNA was not
detected.22 Thus, given the absence of HAS-1 expression
and the low, non-responsive expression of HAS-3, our data
suggests a predominant role for HAS-2 in the synthesis of
HA by bovine articular chondrocytes. Nevertheless, the
effect of these changes in HAS mRNAs will require verifi-
cation at the protein level when antibodies to HAS-1,
HAS-2 and HAS-3 become readily available.
Previous studies have shown that OP-1 induces the
maturation and terminal hypertrophic differentiation of
embryonic chick sternal chondrocytes.32 On the other
hand, OP-1 maintains the chondrocyte phenotype of adult
bovine and human articular chondrocytes without inducing
or promoting hypertrophy.18,19 However, adult articular
chondrocytes may undergo hypertrophy in some condi-
tions, such as during osteoarthritis,33 suggesting that it will
be important to determine whether OP-1, as a potential
therapeutic agent for osteoarthritis, promotes or inhibits
these hypertrophic changes. Also, it has not been deter-
mined whether OP-1 has an effect on osteoarthritic
chondrocytes such as promoting the recovery of degenera-
tive articular cartilage in an animal model of osteoarthritis.
Our work leads to an expectation that OP-1 may be a good
candidate as a therapeutic agent for osteoarthritis, even if it
works only to enhance the biosynthetic and retention
capacity of residual non-diseased chondrocytes. Other
members of the morphogenetic protein/transforming
growth factor- superfamily, may also provide similar ben-
efits. For example, osteogenin (BMP-3) has been shown to
significantly upregulate PG biosynthesis in fetal rat, chick
limb bud and adult rabbit chondrocytes.12,13 BMP-234 and
BMP-415 also enhanced the synthesis of PGs by bovine
articular chondrocytes. Whether these other BMPs have
similar effects as OP-1 on CD44 or HAS expression
remains to be determined.
Osteoarthritis and Cartilage Vol. 8 No. 2 135In conclusion, our findings demonstrate that OP-1 stimu-
lates the mRNA expression of HAS-2, CD44 and aggrecan,
resulting in an increased retention of functional pericellular
matrix by bovine articular chondrocytes cultured in alginate
beads. OP-1 also increases the mRNA expression of
HAS-2 as well as the synthesis and retention of extracellu-
lar matrix in cultured cartilage slices. These results suggest
that OP-1 has potential as a candidate therapeutic for
osteoarthritis. However, more studies are required to
determine the effect of OP-1 on aging, hypertrophic and
osteoarthritic chondrocytes.Acknowledgments
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